Top 18 Zhaoke Ophthalmology Pharmaceutical investors
The most complete profiles first. Showing 18 of 18.
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Andy LinVerified
Venture Capital, Private Equity Firm · China
Health CareGeneticsLife ScienceEmerging MarketsPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Verified email available
Jason ZhaoVerified
Private Equity Firm · China
Health CareGeneticsLife ScienceBiotechnologyPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Verified email available
Jay GuVerified
Venture Capital, Private Equity Firm · China
Health CareGeneticsLife ScienceEmerging MarketsPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Linda CaiVerified
Venture Capital, Private Equity Firm · China
Health CareGeneticsLife ScienceEmerging MarketsPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Brian Chi
Private Equity Firm · China
Health CareGeneticsLife ScienceBiotechnologyPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Contact details available
Chengbin Li
Private Equity Firm · China
Health CareGeneticsLife ScienceBiotechnologyPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Lisa Ye
Private Equity Firm · China
Health CareGeneticsLife ScienceBiotechnologyPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Contact details available
Roy Xie
Venture Capital, Private Equity Firm · China
Health CareGeneticsLife ScienceEmerging MarketsPortfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Remegen18
- Abbisko Therapeutics18
- Evox Therapeutics10
- Repare Therapeutics10
- BioShin10
- PMV Pharmaceuticals10
- Verona Pharma10
- Silverback Therapeutics10
- NewMed Medical10
- Sonendo10
- Protekt Therapeutics10
Frequently asked questions
How many Zhaoke Ophthalmology Pharmaceutical investors are on Angel Roster?
Angel Roster lists 18 Zhaoke Ophthalmology Pharmaceutical investors. 9 of them (50%) include a verified email address.
What types of investors are they?
The most common investor types are Private Equity Firms (18) and Venture Capital Firms (9). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Zhaoke Ophthalmology Pharmaceutical investors invest in?
Among those that list a stage, the most common are Series A (5) and Seed (5).
Where are Zhaoke Ophthalmology Pharmaceutical investors based?
Most are based in China (9), the United States (7) and Israel (2).
Which companies have Zhaoke Ophthalmology Pharmaceutical investors backed?
The most-backed portfolio companies among them are Remegen (18), Abbisko Therapeutics (18), Evox Therapeutics (10), Repare Therapeutics (10) and BioShin (10).
How do I contact Zhaoke Ophthalmology Pharmaceutical investors?
Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.